Recombinant Human CXCL4 Protein，His

CXCL4, also known as platelet factor 4 (PF4), is a CXC chemokine that plays a crucial role in various physiological and pathological processes, including inflammation, angiogenesis, and hematopoiesis. It is primarily secreted by activated platelets and is involved in the recruitment of immune cells to sites of injury or infection. Due to its multifaceted roles, CXCL4 has garnered significant interest in research related to cardiovascular diseases, cancer, and autoimmune disorders. The study of recombinant CXCL4 protein has been pivotal in understanding its structure-function relationships, interaction with receptors, and potential therapeutic applications. Recombinant forms of CXCL4 can be produced in various expression systems, allowing researchers to investigate its biological activities and develop potential therapeutic strategies. For instance, recent studies have highlighted CXCL4's ability to modulate immune responses and inhibit tumor growth, suggesting its promise as a novel biomarker or therapeutic agent. As research progresses, the recombinant CXCL4 protein is being evaluated in preclinical models and clinical trials, paving the way for new insights into its role in human health and disease. Overall, CXCL4 represents a fascinating subject of study within the field of chemokine research, with implications for targeted therapies in inflammatory and neoplastic conditions.